2023
DOI: 10.1111/crj.13620
|View full text |Cite
|
Sign up to set email alerts
|

Clinical characteristics and serum inflammatory markers of community‐acquired mycoplasma pneumonia in children

Abstract: Background To compare the demographic and clinical features, laboratory and imaging findings in mycoplasma pneumoniae pneumonia (MPP) children with non‐MPP (NMPP) children and general MPP (GMPP) children with refractory MPP (RMPP) children and analysis the relationship with the severity of disease. Methods The study included 265 children with MPP and 230 children with NMPP in the Affiliated Changzhou No. 2 People's Hospital of Nanjing Medical University from 2020 to 2021. The children with MPP included RMPP (n… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
5
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 26 publications
(5 citation statements)
references
References 27 publications
0
5
0
Order By: Relevance
“…IL-10, produced by activated macrophages and Th2-cells, is a potent anti-inflammatory cytokine, which reduces the expression of inflammatory cytokine such as TNF-α and alters the function of Th1 lymphocytes and macrophage function, potentially related to the delayed immune response against Mhyo [37,42]. For example, IL-10 overexpression has been described a risk factor for the development of refractory Mycoplasma pneumoniae pneumonia in children [47], suggesting a central role for this cytokine in the development of chronic cases of respiratory infections caused by mycoplasma.…”
Section: Discussionmentioning
confidence: 99%
“…IL-10, produced by activated macrophages and Th2-cells, is a potent anti-inflammatory cytokine, which reduces the expression of inflammatory cytokine such as TNF-α and alters the function of Th1 lymphocytes and macrophage function, potentially related to the delayed immune response against Mhyo [37,42]. For example, IL-10 overexpression has been described a risk factor for the development of refractory Mycoplasma pneumoniae pneumonia in children [47], suggesting a central role for this cytokine in the development of chronic cases of respiratory infections caused by mycoplasma.…”
Section: Discussionmentioning
confidence: 99%
“…Pneumonia is a global concern, and even with widespread vaccination and updated treatment regimens, the morbidity and mortality rates of patients with pneumonia admitted to ICU are still as high as 30%, and those requiring invasive mechanical ventilation are as high as 35–50% [ 1 ]. In recent years, Mycoplasma pneumoniae (MP) has been one of the most common pathogens causing pneumonia, which is characterised by interstitial lung disease and can damage other organs through localized respiratory infections [ 2 ]. Symptoms of infection include fever, cough, sore throat, headache, and rhinitis, and can even be combined with severe lung diseases, such as pulmonary solid changes, pulmonary atelectasis, lung abscess, respiratory distress syndrome, and bronchiectasis [ 3 ].…”
Section: Introductionmentioning
confidence: 99%
“…Moreover, an array of extrapulmonary manifestations, including pulmonary embolism, Stevens-Johnson syndrome, cardiomyopathy, and meningitis, is on the rise. [ 6 , 7 ]…”
Section: Introductionmentioning
confidence: 99%